Opendata, web and dolomites
H2020 projects about "vaccine"
The page lists 186 projects related to the topic "vaccine".
| # | |||
|---|---|---|---|
| 1 | SAPHIR | Strengthening Animal Production and Health through the Immune Response | 2015 |
| 2 | I-MOVE-plus | I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly | 2015 |
| 3 | MycoSynVac | Engineering of Mycoplasma pneumoniae as a broad-spectrum animal vaccine | 2015 |
| 4 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 5 | Paragone | PARAGONE: vaccines for animal parasites | 2015 |
| 6 | DiViNe | Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes | 2015 |
| 7 | BLOODCELLSCROSSTALK | The Crosstalk Between Red And White Blood Cells: The Case Of Fish | 2015 |
| 8 | TOLLerant | Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach. | 2015 |
| 9 | EUROLEISH-NET | Control of leishmaniasis, from bench to bedside and community | 2015 |
| 10 | TBVAC2020 | TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development | 2015 |
| 11 | EMI-TB | Eliciting Mucosal Immunity to Tuberculosis | 2015 |
| 12 | Vaccinesurvey | Monitor population immunity against vaccine preventable diseases | 2015 |
| 13 | MACIVIVA | MAnufacturing process for Cold-chain Independent VIrosome-based VAccines | 2015 |
| 14 | BIZEB | Bio-Imaging of Zoonotic and Emerging Bunyaviruses | 2015 |
| 15 | AUTOOLIGO | Automated synthesis of S. pneumoniae 7F capsular polysaccharide repeating unit as candidate for conjugate vaccines | 2015 |
| 16 | IgEPath | IgEPath - Contributions of IgE-antibodies and IgE effector cells to host defense against pathogenic bacteria | 2015 |
| 17 | IMSTREV | Immune modulation by lymph node stromal cell-derived extracellular vesicles | 2015 |
| 18 | ASF_SwineResistance | African Swine Fever, the Sus scrofa evolutionary genomic response | 2015 |
| 19 | BURK-6 | Investigation of the Type VI secretion system-associated toxins of Burkholderia thailandensis | 2015 |
| 20 | MDR Tuberculosis | Evolution and success of the multi-drug resistant M. tuberculosis SIT41 (LAM7-TUR) lineage | 2015 |
| 21 | LABVaccFish | USE OF LACTIC ACID BACTERIA AS DELIVERY VEHICLE FOR ORAL VACCINATION OF FISH | 2016 |
| 22 | PFSEXOME | Identification of protein kinases and signalling pathways important for Plasmodium falciparum malaria transmission | 2015 |
| 23 | EbolaVac | Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine | 2014 |
| 24 | REACTION | Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans | 2014 |
| 25 | HBV1 | Innate immune responses to human hepatotropic viral infections | 2015 |
| 26 | TWILIGHT | ToWards Immunisations that Last: the Immunology and Gerontology of Helper T cells | 2015 |
| 27 | SVNanoVax | Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy | 2015 |
| 28 | NEWCARBOVAX | New generation of carbohydrate-based vaccines via rational understanding of their immunological mechanism | 2017 |
| 29 | DermalTherapy | Membrane fusion mediated dermal allergy immunotherapy | 2015 |
| 30 | RIPEB | Rapid heat inactivation of pathogens to enable biomarker research | 2015 |
| 31 | EVOLPROOF | Are HPV vaccines ‘evolution-proof’? Multilevel evolutionary ecology of human oncoviruses | 2015 |
| 32 | StableVax | Commercialisation of a world changing invention for the stabilisation and delivery of vaccines | 2015 |
| 33 | CerviVax | New Generation Therapeutic vaccine for the Treatment of HPV infections and Cervical Dysplasia | 2015 |
| 34 | NEURIMMUNE | Neural regulation of immunity | 2015 |
| 35 | BROADimmune | Structural, genetic and functional analyses of broadly neutralizing antibodies against human pathogens | 2015 |
| 36 | EAVI2020 | European AIDS Vaccine Initiative 2020 | 2015 |
| 37 | EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates | 2016 |
| 38 | AML-VACCiN | Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia | 2016 |
| 39 | SAL ETHVI | Innovative, easily applicable vaccine for poultry industry against five Salmonella serovars: Enteritidis, Typhimurium, Hadar, Virchow and Infantis – SAL ETHVI | 2016 |
| 40 | DISSection | Doctoral Industrial School on Human Skin models for Staphylococcal infections | 2016 |
| 41 | FLAVIC DYNAMICS | Labeling Flavivirus capsid protein to unravel its dynamics during infection and egress by correlative super-resolution fluorescence and cryo-electron microscopy | 2017 |
| 42 | GLUTORHIV | Glucose metabolism and mTOR pathway role in CD8+ T cell control of HIV-1 | 2016 |
| 43 | GutBCells | Cellular Dynamics of Intestinal Antibody-Mediated Immune Response | 2016 |
| 44 | SugarBlock | Unraveling the protein glycosylation of Plasmodium falciparum is crucial for development of novel therapeutics against malaria | 2016 |
| 45 | PIGYVAX | Making a yeast-based candidate vaccine against Porcine Epidemic Diarrhea Virus (PEDV) | 2016 |
| 46 | Antibodyomics | Vaccine profiling and immunodiagnostic discovery by high-throughput antibody repertoire analysis | 2016 |
| 47 | PeptiCrad | Personalized oncolytic vaccines for cancer immunotherapy | 2016 |
| 48 | VIREX | Mumps VIRus EXploitation of the human adhesion receptor GPR125 | 2016 |
| 49 | TREGS4DM1 | Commercialization of TREG cells sorting and proliferation in vitro for the production of vaccines for the treatment of type 1 diabetes. | 2016 |
| 50 | 1toStopVax | RNA virus attenuation by altering mutational robustness | 2016 |
| 51 | PHA-ST-TRAIN-VAC | Leveraging Pharmaceutical Sciences and Structural Biology Training to develop 21st Century Vaccines | 2016 |
| 52 | DeNovoImmunoDesign | Computational Design of Novel Functional Proteins for Immunoengineering | 2017 |
| 53 | REUSE4MALARIA | Drug Repurposing for Malaria Chemoprotection | 2016 |
| 54 | ZikaPLAN | Zika Preparedness Latin American Network | 2016 |
| 55 | whyBOTher | Why does Clostridium botulinum kill? – In search for botulinum neurotoxin regulators | 2017 |
| 56 | Baby DCs | Age-dependent Regulation of Dendritic Cell Development and Function | 2017 |
| 57 | VACCELERAID | A novel vaccine technology leading to accelerated availability of vaccines and improved delivery | 2016 |
| 58 | ZIKAVAX | Fast track development of a Zika vaccine based on measles vector | 2016 |
| 59 | CCHFVaccine | Crimean-Congo Haemorrhagic Fever Vaccine | 2017 |
| 60 | MultiViVax | Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria | 2017 |
| 61 | RABYD-VAX | Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine | 2017 |
| 62 | OptiMalVax | Optimizing a deployable high efficacy malaria vaccine | 2017 |
| 63 | ADJUV-ANT VACCINES | Elucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting Vaccines | 2017 |
| 64 | NMR4Nanos | Development and application of NMR-based tools to inorganic nanocarriers for effective vaccine delivery | 2017 |
| 65 | STRUGGLE | Statistical physics of immune-viral co-evolution | 2017 |
| 66 | PDClungSME1 | A therapeutic vaccine candidate for lung cancer based on an exclusive cell line of Plasmacytoid Dendritic Cells (PDC*line) | 2016 |
| 67 | VIVAVE | Viral Vaccine Vectors in Personalized Medicine | 2017 |
| 68 | TracVac | Developing a Chlamydia Trachomatis vaccine | 2017 |
| 69 | FusionPAMPs | New generation of chimeric TLR2-NOD agonist compounds for vaccine adjuvants | 2017 |
| 70 | VSV-EBOVAC | Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV – Sofia ref.: 115842 | 2015 |
| 71 | EBOMAN | Manufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN) – Sofia ref.: 115850 | 2014 |
| 72 | EBOVAC2 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861 | 2014 |
| 73 | EBODAC | Communication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847 | 2014 |
| 74 | EBOVAC1 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854 | 2014 |
| 75 | PERISCOPE | PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910 | 2016 |
| 76 | VAC2VAC | Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924 | 2016 |
| 77 | RESCEU | REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 | 2017 |
| 78 | CD4CRISPR | A quorum sensing mechanism regulating CD4 T cell proliferation | 2017 |
| 79 | HBVssNMR | Investigating the structural role of the Hepatitis B virus core protein C-terminal domain in assembly and maturation using solid-state NMR | 2017 |
| 80 | PolyVac | Polysaccharide-based membrane for sublingual vaccination | 2017 |
| 81 | TANTUMorNEUVACCINE | Neutrophil subtypes: distinct cellular targets for therapeutic intervention | 2017 |
| 82 | BoVLP-BVD | Development of Tagged (DIVA), Virus-Like-Particle polyantigenic Vaccine against Bovine Viral Diarrhea virus (BVDc) | 2017 |
| 83 | PIGSs | Program for Innovative Global Prevention of Streptococcus suis. | 2017 |
| 84 | IMMOVA | Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease | 2017 |
| 85 | SynVaccine | Rational Design and Construction of Viral Based Products | 2017 |
| 86 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2017 |
| 87 | PEVIA | PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088 | 2017 |
| 88 | AUTOCOMPLEMENT | The role of complement in the induction of autoimmunity against post-translationally modified proteins | 2017 |
| 89 | Super-Vaccine | Exploring the potential applications of live viral vaccine encoded small-hairpin-RNAs in improving both vaccine safety and efficacy through RNA-interference and stimulation of the innate immune system | 2018 |
| 90 | VSV-EBOPLUS | SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068 | 2016 |
| 91 | TRANSVAC2 | European Vaccine Research and Development Infrastructure | 2017 |
| 92 | DRIVE | Development of Robust and Innovative Vaccine Effectiveness | 2017 |
| 93 | ETVAX | ETVAX – the first oral vaccine for protection against traveller’s diarrhoea caused by ETEC | 2017 |
| 94 | ANTHEM | ANTHEM: A Novel Tolerogenic vaccine for the treatment of antibodies in HaEMophilia | 2017 |
| 95 | IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer | 2017 |
| 96 | NanoBioMap | Nanoparticle Biointerface Mapping | 2018 |
| 97 | SI | Structural and functional characterization of the ICOS/ICOSL immune complex | 2018 |
| 98 | ToCCaTa | Tailoring the functional Capacity of Cytotoxic T cells for future Therapies | 2018 |
| 99 | FINDER | FINDER: FIghtiNg DEngue viRus, a novel strategy for the development of fully protective antiviralsthat act by disrupting the DENV NS3/NS5 interaction | 2018 |
| 100 | SEXinMALARIA | Sex in malaria parasites – from basic biology to targets for transmission blocking interventions. | 2018 |
| 101 | HGB-StIC | Human Genetic Basis of Severe Staphylococcal Infections in Childhood | 2019 |
| 102 | MTBHLAE | Investigation of a novel immune cell type in Tuberculosis: characterization of the specificity, function and pathogen killing ability of T cells restricted by non-classical HLA-E molecules | 2018 |
| 103 | FluPRINT | Tracing the inFLUenza vaccine imPRINT on immune system to identify cellular signature of protection | 2018 |
| 104 | ENGEMED | Simulating the dynamics of viral evolution: A computer-aided study toward engineering effective vaccines | 2018 |
| 105 | VACMA | Vaccine Media Analytics | 2018 |
| 106 | GammaDelta | DECIPHERING THE MEMORY OF gd T CELLS: DOES IT HAVE A ROLE IN CROSS-PROTECTION OF BACILLE CALMETTE-GUERIN VACCINATION? | 2018 |
| 107 | 2STOP_TBE | Structural Openings to Understand and Prevent Tick Borne Encephalitis | 2018 |
| 108 | PHINDaccess | Strengthening Omics data analysis capacities in pathogen-host interaction | 2018 |
| 109 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
| 110 | Pharma-Factory | Building the product pipeline for commercial demonstration of Plant Molecular Factories | 2017 |
| 111 | BIOCOPY | BIOCOPY: the new biomolecule copying and screening solution for diagnostics and therapeutics | 2018 |
| 112 | RV001 | RV001: An anti-metastatic cancer vaccine | 2018 |
| 113 | EBOVAC3 | Bringing a prophylactic Ebola vaccine to licensure | 2018 |
| 114 | HIPShot | HBV GenetIc and Proteomic Screen | 2019 |
| 115 | RAPID | RNA particles for Preparedness against Infectious Diseases | 2018 |
| 116 | VacPath | Novel vaccine vectors to resist pathogen challenge | 2019 |
| 117 | vAMRes | Vaccines as a remedy for antimicrobial resistant bacterial infections | 2018 |
| 118 | UNIFLUVAC | A novel universal influenza vaccine targeting epitopes of limited variability | 2018 |
| 119 | PGEN | Automated evaluation and correction of generation bias in immune receptor repertoires | 2019 |
| 120 | ImmunoCode | Digital Single Cell Immunology: Decoding Cellular Interactions for Improved Immunotherapy | 2018 |
| 121 | BGV1 | New vaccine for a paradigm shift in Brucellosis | 2018 |
| 122 | PanCaVax | Personalised Pancreatic Cancer Vaccination Therapy derived from Autologous Tumor Cells and Neoantigens | 2018 |
| 123 | LIPOBITS | Liposome-based Biomimetic Treatment for auto-immune diabetes (T1D) | 2018 |
| 124 | GLIOVACC | Augmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands | 2018 |
| 125 | Sugar-Enable | Influenza Virus - Sugar Interactions, From Glycan Arrays To Better Vaccines | 2018 |
| 126 | SyrinJector | SyrinJector, the first smart device for livestock mass vaccination. | 2018 |
| 127 | COMPLEXDYNAMICS-PHIM | On the Origin of Complex Dynamics in Multi-strain Models: Insights for Public Health Intervention Measures | 2019 |
| 128 | POLYMMUNE | Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment | 2019 |
| 129 | FuncMAB | High-throughput single-cell phenotypic analysis of functional antibody repertoires | 2019 |
| 130 | FRINGE | Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies | 2019 |
| 131 | VITAL | Vaccines and Infectious Diseases in the Ageing PopuLation | 2019 |
| 132 | BIONICbacteria | Integrating a novel layer of synthetic biology tools in Pseudomonas, inspired by bacterial viruses | 2019 |
| 133 | skILL | Intracellular signalling by modified lipopolysaccharide | 2019 |
| 134 | SUPRAVACC | Supramolecular engineering of glycan-decorated peptides as synthetic vaccines | 2019 |
| 135 | iReceptor Plus | ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY | 2019 |
| 136 | RECODID | Integrated human data repositories for infectious disease-related international cohorts to foster personalized medicine approaches to infectious disease research | 2019 |
| 137 | EpIg Men | The Role of Antibodies (Ig) and the Respiratory Epithelium in the Prevention of Invasive Meningococcal Infections in Different Age Groups | 2019 |
| 138 | FAKEOLOGY | Fake news and pseudo-science as post-modern mythology: The case of the anti-vaccination movement | 2019 |
| 139 | Need2immune | Personalized liposomal cancer vaccines within days by rapid formulation screening | 2019 |
| 140 | FUSEDESIGN | Model-guided design of a stabilized pre-fusion class III viral fusogen, rabies virus glycoprotein | 2019 |
| 141 | LUNG-BIM | Induction of B cell immunity in the lung mucosa | 2019 |
| 142 | ARGONAUT | ARGONAUT: from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy | 2019 |
| 143 | CRUZIVAX | Vaccine for prevention and treatment of Trypanosoma cruzi infection | 2019 |
| 144 | SHIGETECVAX | Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea | 2019 |
| 145 | DISCOURSEVAX | Institutional Theory and Discourse Analysis: an empirical investigation of the rhetoric of Anti Vaccination movement | 2020 |
| 146 | BoVLP-BVD | Tagged (DIVA) polyantigenic vaccine against Bovine Viral Diarrhea virus (BVDv) based on virus-Like-Particles | 2019 |
| 147 | Vacc-iNTS | Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa | 2019 |
| 148 | VASA | Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa | 2019 |
| 149 | VECTRACK | Earth observation service for preventive control of insect disease vectors | 2019 |
| 150 | PnuBioVax | PnuBioVax™: next-generation vaccine for a personalised and effective immune response against Streptococcus pneumoniae. | 2019 |
| 151 | ImmuniPrDx | PrDx - Advanced Software for Predicting the Immune Response During Drug Development | 2019 |
| 152 | OvaVAx | 100% Bacteria free eggs for use in production of human and animal vaccines | 2019 |
| 153 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2019 |
| 154 | VACCIBIOME | Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy | 2019 |
| 155 | TK-NEO | Personalized Cancer Immunotherapy through DNA-EP vaccines | 2019 |
| 156 | FRAME | FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf | 2019 |
| 157 | BactiVax | anti-Bacterial Innovative Vaccine Training Network. | 2019 |
| 158 | RSVTriVax | Development of a trivalent epitope-focused RSV vaccine to boost pre-existing immunity | 2019 |
| 159 | ECRC | Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola | 2019 |
| 160 | PAVE | A nanovaccine Approach for the treatment of Pancreatic Cancer | 2019 |
| 161 | VACDIVA | A safe DIVA vaccine for African Swine Fever control and eradication | 2019 |
| 162 | RV001 | RV001: An anti-metastatic cancer vaccine | 2019 |
| 163 | vACCINE | AeronautiCal Cyber INtrusion dEtection mechanism | 2019 |
| 164 | TRAIN-OLD | Trained immunity: improving the next generation of vaccines for the older generation | 2019 |
| 165 | VIVA | Vaccine development against variable pathogens | 2020 |
| 166 | MaxONCO | A cancer vaccine to boost body’s natural defences to fight chordoma and head and neck cancer | 2020 |
| 167 | FIDA | Scale-up of our disruptive antibody analytical platform based in flow-induced dispersion analysis (FIDA) to increase efficiency in the research of new antibodies and vaccines | 2019 |
| 168 | COMBINE | Collaboration for Prevention and Treatment of MDR Bacterial Infections | 2019 |
| 169 | PAVax | A training network for the design of new synthetic carbohydrate-based vaccines to combat antibiotic resistant Pseudomonas aeruginosa | 2020 |
| 170 | IP-cure-B | Immune profiling to guide host-directed interventions to cure HBV infections | 2020 |
| 171 | TherVacB | THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B | 2020 |
| 172 | DPR-VAX | Dipeptide-Repeat Vaccine to prevent ALS and FTD in C9orf72 mutation carriers | 2020 |
| 173 | ISOLDA | Improved Vaccination Strategies for Older Adults | 2020 |
| 174 | INDIGO | Effective and Affordable Flu Vaccines for the World | 2020 |
| 175 | ENDFLU | Evaluation of ratioNally Designed Influenza vaccines | 2020 |
| 176 | MATCH | Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research | 2020 |
| 177 | INCENTIVE | Indo-European Consortium for Next Generation Influenza Vaccine Innovation | 2020 |
| 178 | RNAVirFitness | The dark side of evolution: the deleterious mutational landscape of RNA viruses | 2020 |
| 179 | KineTic | New Reagents for Quantifying the Routing and Kinetics of T-cell Activation | 2020 |
| 180 | BGV1 | New vaccine for a paradigm shift in Brucellosis, one of the world’s most widespread zoonotic diseases affecting humans | 2020 |
| 181 | QS21-Mech | Target identification and elucidation of the molecular mechanism of action of saponin vaccine adjuvants QS-21 (QS21Mech) | 2020 |
| 182 | Valvax | Evaluating the Long-Run Socioeconomic Effects of Childhood Vaccination | 2020 |
| 183 | DYNAMOD-VACCINE-DATA | A new method for dynamic opinion modelling of surveys applied to vaccine hesitancy data | 2020 |
| 184 | VacTrack | Dissecting the protection mechanism of new generation vaccines by synchronizing systems biology with in vivo imaging | 2021 |
| 185 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |
| 186 | FUSION | Single Molecule Imaging-based design of HIV-1 vaccines | 2020 |